| Pharmaceutical Information |
| Drug Name |
Tolazoline hydrochloride |
| Drug ID |
BADD_D02239 |
| Description |
A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn. |
| Indications and Usage |
For the treatment of pulmonary artery anomalies |
| Marketing Status |
approved; vet_approved |
| ATC Code |
M02AX02; C04AB02 |
| DrugBank ID |
DB00797
|
| KEGG ID |
D00997
|
| MeSH ID |
D014043
|
| PubChem ID |
6048
|
| TTD Drug ID |
D03RZV
|
| NDC Product Code |
Not Available |
| UNII |
E669Z6S1JG
|
| Synonyms |
Tolazoline | Benzalolin | Priscoline | Priscol | Tolazoline Hydrochloride | Tolazoline Monohydrochloride | Divascol | Pridazole |
|
| Chemical Information |
| Molecular Formula |
C10H13ClN2 |
| CAS Registry Number |
59-97-2 |
| SMILES |
C1CN=C(N1)CC2=CC=CC=C2.Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
